Built the scientific foundation for a biomarker strategy from scratch, including assay development for a target with no existing detection method and cross-functional coordination across regulatory, clinical, and medical teams.

Supported pre-IND preparation for a cell therapy and device combination product, including protocol standardization, cGMP formatting, and donor screening documentation.

Validated and scoped biological applications for a novel technology platform, then built the lab infrastructure and proof-of-concept experiments needed to support their next funding round.

Developed proof-of-concept assays for an oral drug delivery device and served as the team's scientific resource across drug delivery, antibody manufacturing, and IP landscape work.

Developed chromatin isolation protocols for a novel microchip platform and identified which scientific communities would find the most value in the technology.

Helped translate a novel computational tool's value to biological audiences and supported outreach to potential biotech partners.

Developed protocols for placental cell isolation and characterized transcription factors regulating trophoblast differentiation.